Clinical Trial Update: Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing oxaliplatin/5-FU/leucovorin with and without vatalanib in previously treated metastatic colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer
• Colorectal Cancer
• Rectal Cancer

Drugs mentioned

• Adrucil (5-fluorouracil)
• Eloxatin (oxaliplatin)
• Vatalanib (vatalanib)
• Wellcovorin (leucovorin calcium)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Colorectal Neoplasms, Colonic Neoplasms | Phase 3 | Status: COMPLETED